Bladder cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-80 years old; 2. The pathological and imaging diagnosis was non-muscular invasive urothelial carcinoma of bladder. 3. Male patients with follow-up information for 5 years or more after diagnosis and treatment; 4. The main organs (heart, liver, lung, kidney) function is basically normal, PS score: 0-2; 5. Bladder volume>=200ml.
Exclusion criteria
Exclusion criteria: 1. Bladder adenocarcinoma, bladder small cell carcinoma, bladder clear cell carcinoma, bladder carcinoid and other non-bladder urothelial carcinoma 2. Metastatic bladder cancer or other cancers involving the bladder; 3. Participants considered inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Countries
China
Contacts
Shanghai General Hospital